Greenway Magazine
by PHYTOS
26 July 2021
Phytos Manufacturing, a BeLeaf Medical Company, is proud to announce a partnership with Ananda Brands and the launch of the midose. line of products. Verve, the first midose. product on the market, is an uplifting blend of all-natural botanical ingredients in a dose controlled, all-in-one vape pen. The vape pens were made available earlier this spring and are now in over 30 dispensaries in Missouri. A second product, quick dissolve sublingual tablets called midose. melts, will be available in the next few weeks. The positive feedback from patients has created great demand for the products all over the state.
“We want to be there for patients who are on the journey to achieve holistic wellness and balance in their daily life. We designed midose. (as in “my dose”) to be simple and straightforward to use, says Kate Simpson, Co-founder and Marketing Director with Ananda Brands, “there are 3 varieties of all-natural botanical blends that guide you toward what to expect from each one—whether it’s calm, clarity, or zzzs. Since each inhale and melt is precisely measured into a microdose, patients can feel confident that they are in the right zone every time.”
The 500mg, all-in-one midose. vape pen consists of ratios of THC and CBD, all-natural terpenes and botanical blends for the needs of anxiety relief, energy/focus and night time rest. These vape pens are dose controlled, allowing consistent 3 second pulls each time with the dosage hovering around 3mg THC per draw. This allows the patient to fully decide how many draws they need to feel just right in a controlled way.
midose. melts, a sublingual, quick-dissolve tablet, are all-natural with blends of 3mg THC and CBD ratios, terpenes and curated botanicals. These melts dissolve under the tongue within 1 minute and immediately enter the bloodstream allowing effects to be felt within 5 – 20 minutes, a much quicker onset than a gummy, capsule or other edible product. A traditional edible has to be digested and pass through the liver, delaying effects for up to an hour or more.
Finding the perfect balance is a personal process since each person reacts to cannabis differently. There’s no such thing as a “standard dose” and this is where the concept of microdosing is primed to take out the guessing games. Microdosing is taking the “low & slow” approach to cannabis and is gaining traction in the growing cannabis space. There used to be many variables around cannabis but that’s why midose. was created, to allow patients to maximize their health and well-being with an all-natural dose that works for them. “Consistency is key with midose.” Phytos Chief Science Officer, Stephanie Cernicek said. “We created a product that provides patients with precise control over their experience. Each batch is tested twice to ensure the potency is exact and automated filling machines have been fine-tuned and calibrated to precisely fill each pen to exactly 500mg. We are excited to produce midose. products. After years of research and development, midose. has arrived with specifically formulated products, putting patients in control of their experience.”
About: PHYTOS leverages BeLeaf’s industry-leading experience and scientific rigor to bring unmatched exactitude to cannabis in Missouri. Dedicated hi-tech facilities make it possible for PHYTOS to produce reliable, safe, and meticulously consistent cannabis free from all variables. Highly controlled growing environments separated by stage and strain, to a range of extraction methods creates superior cannabis. PHYTOS offers CO2 extraction, efficient Ethanol extraction, and now state-of-the-art Hydrocarbon extraction—which allows us to immediately freeze freshly trimmed cannabis and extract more quickly, preserving delicate terpenes for a superior extract and producing live-resin products on-site. These science-backed systems and proprietary formulations have made the PHYTOS name synonymous with precision.
The post PHYTOS launches Missouri’s first microdose line of products, midose. appeared first on Greenway Magazine.